Method of treating hepatitis delta viral infection

Details Method of treating hepatitis delta viral infection Method of treating hepatitis delta viral infection

A - Human Necessities

61

K

A61K 31/7072 (2006.01) A61P 31/14 (2006.01)

Patent

CA 2405502

A method for the treatment for hepatitis delta infection in a host, that includes administering an effective amount of a nucleoside or a nucleoside analog or a prodrug or pharmaceutically acceptable salt thereof that suppresses the expression of the hepatitis B surface or preS1 antigen in the host 100-fold or more relative to pretreatment values in vivo; or to not move than 1 microgram per milliliter in vivo. In a preferred embodiment, the nucleoside is L-FMAU, or a pharmaceutically acceptable salt or prodrug thereof.

L'invention concerne un procédé de traitement d'une infection par le virus de l'hépatite D chez un hôte, consistant à administrer une quantité efficace d'un nucléoside ou d'un analogue de nucléoside, ou un promédicament ou un sel de celui-ci pharmaceutiquement acceptable qui supprime de 100 fois ou plus, ou d'un microgramme ou moins par millilitre, l'expression d'un antigène de surface de l'hépatite B ou d'un antigène preS1 chez l'hôte par rapport au valeurs de prétraitement in vivo. Selon un mode de réalisation, le nucléoside est L-FMAU, ou un sel pharmaceutiquement acceptable, ou un pro-médicament de celui-ci.

Affiliated with

Also associated with

Rating

Method of treating hepatitis delta viral infection does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treating hepatitis delta viral infection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating hepatitis delta viral infection will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1688251